| CAS No. | 212142-18-2 |
|---|---|
| MDL No. | N/A |
| MF | C24H21ClN4O4 |
| MW | 464.90 |
| InChI Key | LLDWLPRYLVPDTG-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 50 mg | 99% | $126 | In Stock | |
| 100 mg | 99% | $239 | In Stock | |
| 250 mg | 99% | $367 | In Stock | |
| 1 g | 99% | $1086 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Vatalanib succinate is a succinate salt formed by combining vatalanib with one molar equivalent of succinic acid. It is a multi-targeted tyrosine kinase inhibitor that acts on all isoforms of VEGFR, PDGFR, and c-Kit. It functions as an angiogenesis inhibitor, antineoplastic agent, EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor, and vascular endothelial growth factor receptor antagonist. It contains vatalanib.
| CAS No. | 212142-18-2 |
|---|---|
| Product Name | Vatalanib Succinate |
Irritant
Health Hazard